|
|
||||||||
The Journal of Immunology, Vol 150, Issue 3 1029-1035, Copyright © 1993 by American Association of Immunologists
ARTICLES |
A Caruso, L Tiberio, C De Rango, C Bonfanti, G Flamminio, G Gribaudo, E Monti, E Viani, N Manca and G Garotta
Institute of Microbiology, University of Brescia, Italy.
To gain more information about the relationship between the structure of IFN-gamma and its activity, a peptide corresponding to a hydrophilic peak between amino acids 4 and 16 was used to immunize mice and generate mAb. mAb IGMB-15 reacts to both native and rIFN-gamma and neutralizes the antiproliferative activity of IFN-gamma without affecting its antiviral activity or its ability to up-regulate HLA-DR Ag expression. Moreover, we observed that mAb IGMB-15 was unable to inhibit the binding of radiolabeled IFN-gamma to its cellular receptor. These findings show that the NH2-terminal region may somehow be involved in the biologic activity of IFN-gamma. Besides, the capability of mAb IGMB-15 to inhibit the antiproliferative but not the antiviral activity of IFN-gamma in the same cell (HEp-2) suggests the presence of different elements involved in signal transduction, which may account for the multiple activities of the lymphokine.
This article has been cited by other articles:
![]() |
M. A. De Francesco, M. Baronio, S. Fiorentini, C. Signorini, C. Bonfanti, C. Poiesi, M. Popovic, M. Grassi, E. Garrafa, L. Bozzo, et al. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor PNAS, July 23, 2002; 99(15): 9972 - 9977. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Beretich Jr., P. B. Carter, and E. A. Havell Roles for Tumor Necrosis Factor and Gamma Interferon in Resistance to Enteric Listeriosis Infect. Immun., May 1, 1998; 66(5): 2368 - 2373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |